Chordate Medical Holding AB (publ) (STO:CMH.PREF)

STO:CMH.PREF Revenue

Chordate Medical Holding AB had revenue of 607.74K SEK in the quarter ending March 31, 2025, a decrease of -4.84%. This brings the company's revenue in the last twelve months to 2.41M, up 6.49% year-over-year. In the year 2024, Chordate Medical Holding AB had annual revenue of 2.44M with 39.85% growth.

• Revenue (ttm): 2.41M
• Revenue Growth: +6.49%
• P/S Ratio: 6.83
• Revenue / Employee: 804.03K
• Employees: 3
• Market Cap: 16.47M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.44M	696.10K	39.85%
Dec 31, 2023	1.75M	1.64M	1,509.77%
Dec 31, 2022	108.52K	-2.07M	-95.03%
Dec 31, 2021	2.18M	-1.43M	-39.57%
Dec 31, 2020	3.61M	663.38K	22.49%